Clinical Advancements of Targeted Antibody-Drug Conjugates in Breast and Lung Cancer
OncLive,
This article surveils key advancements in the role of antibody-drug conjugates in solid tumors by examining important clinical…
Novel ADC Appears to Leverage TROP2 Expression in NSCLC
OncLive,
Investigators aim to expand the treatment portfolio with the phase 3 TROPION-LUNG01 trial, which is designed to examine…
Investigational ADC is Well Tolerated with Partial-Dose-depended Response in NSCLC
Medical Health News,
Square of Spain - National museum of Barcelona with fountain at summer day, Spain, retro toned Results of a Phase I clinical…
Updated Clinical Results and New Biomarker Analyses Presented for Daiichi Sankyo's DS-1062 in Patients with Advanced NSCLC at 2019 World Conference on Lung Cancer
Biospace,
Updated results presented for investigational TROP2 targeting ADC DS-1062 in unselected patients with unresectable advanced…